178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Bone drug may be beneficial for knee osteoarthritis

Bone drug may be beneficial for knee osteoarthritis

by Boston University School of MedicineCredit: CC0 Public DomainBisphosphonates (a class of drugs that prevent the loss of bone density and used to treat osteoporosis and similar diseases) appear

Bone drug may be beneficial for knee osteoarthritis

by Boston University School of MedicineCredit: CC0 Public DomainBisphosphonates (a class of drugs that prevent the loss of bone density and used to treat osteoporosis and similar diseases) appear
Can losing weight combat the structural defects of knee osteoarthritis?

Can losing weight combat the structural defects of knee osteoarthritis?

by WileyCredit: CC0 Public DomainIn a study published inArthritis & Rheumatology, a decrease in body mass index (BMI) was associated with both a lower incidence of the structural defect

Can losing weight combat the structural defects of knee osteoarthritis?

by WileyCredit: CC0 Public DomainIn a study published inArthritis & Rheumatology, a decrease in body mass index (BMI) was associated with both a lower incidence of the structural defect
Many risk factors contribute to worsening of quality of life in people with knee OA

Many risk factors contribute to worsening of quality of life in people with knee OA

by University of Eastern FinlandCredit: CC0 Public DomainA new study from the University of Eastern Finland shows that the health-related quality of life of most people who have had or have a hig

Many risk factors contribute to worsening of quality of life in people with knee OA

by University of Eastern FinlandCredit: CC0 Public DomainA new study from the University of Eastern Finland shows that the health-related quality of life of most people who have had or have a hig
A tiny molecule with a big impact

A tiny molecule with a big impact

by Otto-von-Guericke-Universität MagdeburgProf. Dr. Andreas J. Müller, Head of the Intravital Microscopy of Infection and Immunity Group, Institute of Molecular and Clinical Immunology, Faculty of Med

A tiny molecule with a big impact

by Otto-von-Guericke-Universität MagdeburgProf. Dr. Andreas J. Müller, Head of the Intravital Microscopy of Infection and Immunity Group, Institute of Molecular and Clinical Immunology, Faculty of Med
Study suggests staying current with COVID-19 vaccinations helps combat emerging variants

Study suggests staying current with COVID-19 vaccinations helps combat emerging variants

by Erik Robinson,Oregon Health & Science UniversityA COVID-19 vaccine is prepped at an OHSU clinic. New research from OHSU reveals a strong immune response to an updated vaccine in the fall

Study suggests staying current with COVID-19 vaccinations helps combat emerging variants

by Erik Robinson,Oregon Health & Science UniversityA COVID-19 vaccine is prepped at an OHSU clinic. New research from OHSU reveals a strong immune response to an updated vaccine in the fall
MyD88—villain of allergies and asthma

MyD88—villain of allergies and asthma

by Lydia Goff ,Duke UniversityFlorescence microscopy image of mouse dendritic cells with mRNA-loaded blood cells.Even if you don't have allergies yourself, I guarantee you can list at

MyD88—villain of allergies and asthma

by Lydia Goff ,Duke UniversityFlorescence microscopy image of mouse dendritic cells with mRNA-loaded blood cells.Even if you don't have allergies yourself, I guarantee you can list at
Better than a pill: Team to develop new arthritis treatment via silk

Better than a pill: Team to develop new arthritis treatment via silk

by Erika Ebsworth-Goold,Washington University School of Medicine in St. LouisA team of researchers from Washington University in St. Louis will use silk micro-particles, like the ones pictured h

Better than a pill: Team to develop new arthritis treatment via silk

by Erika Ebsworth-Goold,Washington University School of Medicine in St. LouisA team of researchers from Washington University in St. Louis will use silk micro-particles, like the ones pictured h
Groundbreaking study reveals clues to predict mortality in rare VEXAS syndrome

Groundbreaking study reveals clues to predict mortality in rare VEXAS syndrome

by American College of RheumatologyHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/Wikiped

Groundbreaking study reveals clues to predict mortality in rare VEXAS syndrome

by American College of RheumatologyHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/Wikiped
TAp63: A new protein drug target for rheumatoid arthritis

TAp63: A new protein drug target for rheumatoid arthritis

by Chiba UniversityGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.164778Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The

TAp63: A new protein drug target for rheumatoid arthritis

by Chiba UniversityGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.164778Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The
A key gene modifies regulatory T cells to fine-tune the immune response

A key gene modifies regulatory T cells to fine-tune the immune response

by Salk InstituteA histology image showing inflammation in colon epithelium. Weakening of regulatory T cell function induces infiltration of immune cells (small blue dots) into colon epithelium (

A key gene modifies regulatory T cells to fine-tune the immune response

by Salk InstituteA histology image showing inflammation in colon epithelium. Weakening of regulatory T cell function induces infiltration of immune cells (small blue dots) into colon epithelium (
Upadacitinib beats placebo for psoriatic arthritis

Upadacitinib beats placebo for psoriatic arthritis

For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J

Upadacitinib beats placebo for psoriatic arthritis

For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J
Multifactorial mechanisms underlie leg weakness in hip OA

Multifactorial mechanisms underlie leg weakness in hip OA

Multiple factors contribute to leg weakness in people with hip osteoarthritis, with muscle atrophy being the strongest contributor, according to the results of a systematic review published online Jul

Multifactorial mechanisms underlie leg weakness in hip OA

Multiple factors contribute to leg weakness in people with hip osteoarthritis, with muscle atrophy being the strongest contributor, according to the results of a systematic review published online Jul